Newborn congenital cytomegalovirus screening and hearing outcomes: a systematic review of current literature

Document Type

Article

Publication Date

10-1-2024

Publication Title

Current opinion in otolaryngology & head and neck surgery

Abstract

PURPOSE OF REVIEW: The purpose of this review is to summarize the very recent literature surrounding hearing outcomes of children with congenital cytomegalovirus (cCMV) detected through systematic screening programs.

RECENT FINDINGS: There are several different approaches to cCMV screening including forms of targeted vs. universal screening of newborns as well as maternally-derived prenatal testing. However, many studies fail to document hearing-related outcomes both in the newborn period and further into childhood when late-onset sensorineural hearing loss (SNHL) can occur. This systematic review included studies of neonates screened for cCMV reporting hearing outcomes for at least one point in time. Hearing targeted screening appeared the most widely reported for detection of unilateral and bilateral SNHL in those with cCMV. A few studies examined these clinical findings in relation to antiviral treatment.

SUMMARY: Congenital CMV is an important and common cause of childhood hearing loss. Newborn screening programs may expand opportunities for early diagnosis and treatment of the infection and its sequelae.

Medical Subject Headings

Humans; Cytomegalovirus Infections; Neonatal Screening; Infant, Newborn; Hearing Loss, Sensorineural; Hearing Tests

PubMed ID

39146216

ePublication

ePub ahead of print

Volume

32

Issue

5

First Page

329

Last Page

338

Share

COinS